StemCell Institute Inc. (7096.T)
JPY 1315.0
(2.02%)
JPY 1315.0
(2.02%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 6.67 Million JPY | 46.56% |
| 2022 | 4.55 Million JPY | 0.0% |
| 2021 | - JPY | 0.0% |
| 2020 | - JPY | 0.0% |
| 2019 | - JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - JPY | 0.0% |
| 2023 Q4 | 6.67 Million JPY | 0.0% |
| 2023 Q3 | - JPY | 0.0% |
| 2023 Q2 | - JPY | 0.0% |
| 2023 Q1 | - JPY | -100.0% |
| 2023 FY | 6.67 Million JPY | 46.56% |
| 2022 Q3 | - JPY | 0.0% |
| 2022 Q2 | - JPY | 0.0% |
| 2022 Q4 | 4.55 Million JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 767.03 Million JPY | 99.13% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 2 Billion JPY | 99.666% |
| Linical Co., Ltd. | 1.49 Billion JPY | 99.555% |
| Trans Genic Inc. | 1.32 Billion JPY | 99.497% |
| MEDINET Co., Ltd. | 781 Thousand JPY | -754.802% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.34 Billion JPY | 99.716% |
| AnGes, Inc. | 214.94 Million JPY | 96.894% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | 93.752% |
| Nxera Pharma Co., Ltd. | 63.21 Billion JPY | 99.989% |
| Immuno-Biological Laboratories Co., Ltd. | 84.56 Million JPY | 92.105% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | 99.398% |
| Carna Biosciences, Inc. | 28.4 Million JPY | 76.495% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 875.59 Million JPY | 99.238% |
| RaQualia Pharma Inc. | 39.05 Million JPY | 82.904% |
| Chiome Bioscience Inc. | - JPY | -Infinity% |
| Kidswell Bio Corporation | 1.83 Billion JPY | 99.637% |
| PeptiDream Inc. | 19.63 Billion JPY | 99.966% |
| Oncolys BioPharma Inc. | 161.1 Million JPY | 95.856% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 397 Million JPY | 98.318% |
| Healios K.K. | 450 Million JPY | 98.516% |
| BrightPath Biotherapeutics Co., Ltd. | - JPY | -Infinity% |
| Kubota Pharmaceutical Holdings Co., Ltd. | - JPY | -Infinity% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 77.29 Million JPY | 91.363% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 773.29 Million JPY | 99.137% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 788 Million JPY | 99.153% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 491.35 Million JPY | 98.641% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 143.75 Million JPY | 95.356% |